Assessment of myeloperoxidase and oxidative α1-antitrypsin in patients on hemodialysis

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 1, 2009, Pages 142-151

  Honda, Hirokazu ^a   Ueda, Masashi ^b   Kojima, Shiho ^b   Mashiba, Shinichi ^b   Hirai, Yuki ^a   Hosaka, Nozomu ^a   Suzuki, Hiroki ^a   Mukai, Masanori ^a   Watanabe, Makoto ^a   Takahashi, Keiko ^c   Shishido, Kanji ^c   Akizawa, Tadao ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ikagaku Co Ltd   (Japan)

^c Kawasaki Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; BIOLOGICAL MARKER; PEROXIDASE; SERPINA1 PROTEIN, HUMAN;

ADULT; ALBUMIN BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN CALORIE MALNUTRITION; AGED; BLOOD; CAROTID ARTERY; CAROTID ARTERY DISEASE; CHRONIC KIDNEY FAILURE; ECHOGRAPHY; INTIMA; MIDDLE AGED; NUTRITIONAL STATUS; PREDICTION AND FORECASTING; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TUNICA MEDIA; UPREGULATION;

AGED; ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OXIDATIVE STRESS; PEROXIDASE; PREDICTIVE VALUE OF TESTS; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; UP-REGULATION;

EID: 64049108535     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02280508     Document Type: Article

References (35)

1. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911, 1999
2. Pawlak K, Pawlak D, Mysliwiec M: Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis 190: 199-204, 2007 (Pubitemid 44908316)
3. Bayes B, Pastor MC, Bonal J, Foraster A, Romero R: Oxidative stress, inflammation and cardiovascular mortality in haemodialysis. Role of seniority and intravenous ferrotherapy: Analysis at 4 years of follow-up. Nephrol Dial Transplant 21: 984-990, 2006
4. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15: 953-960, 2000 (Pubitemid 30410364)
5. Maruyama Y, Lindholm B, Stenvinkel P: Inflammation and oxidative stress in ESRD - The role of myeloperoxidase. J Nephrol 17(Suppl 8): S72-S76, 2004 (Pubitemid 44178743)
6. Nicholls SJ, Hazen SL: Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25: 1102-1111, 2005
7. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Münzel T, Simoons ML, Hamm CW; CAPTURE Investigators: Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108: 1440-1445, 2003 (Pubitemid 37176448)
8. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL: Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286: 2136-2142, 2001 (Pubitemid 34041599)
9. Borawski J: Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: The underestimated modifying effects of heparin. Am J Kidney Dis 47: 37-41, 2006
10. Kaysen GA, Levin NW, Mitch WE, Chapman AL, Kubala L, Eiserich JP: Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients. Blood Purif 24: 508-516, 2006 (Pubitemid 46030091)
11. Kalantar-Zadeh K, Brennan ML, Hazen SL: Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis 48: 59-68, 2006 (Pubitemid 43912943)
12. Kalantar-Zadeh K, Balakrishnan VS: The kidney disease wasting: Inflammation, oxidative stress, and diet-gene interaction. Hemodial Int 10: 315-325, 2006 (Pubitemid 44489914)
13. Meuwese MC, Trip MD, van Wissen S, van Miert JN, Kastelein JJ, Stroes ES: Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia. Atherosclerosis 197: 916-921, 2008
14. Matheson NR, Wong PS, Travis J: Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun 88: 402-409, 1979
15. Ueda M, Mashiba S, Uchida K: Evaluation of oxidized alpha-1-antitrypsin in blood as an oxidative stress marker using anti-oxidative alpha1-AT monoclonal antibody. Clin Chim Acta 317: 125-131, 2002 (Pubitemid 34114027)
16. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volumeKt/V: An analysis of error. J Am Soc Nephrol 4: 1205-1213, 1993
17. Shinzato T, Nakai S, Fujita Y, Takai I, Morita H, Nakane K, Maeda K: Determination of Kt/V and protein catabolic rate using pre- and postdialysis blood urea nitrogen concentrations. Nephron 67: 280-290, 1994 (Pubitemid 24177635)
18. Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S, Kumagai H: Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 87: 106-113, 2008
19. Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent JP, Nicolis I, Benazeth S, Cynober L, Aussel C: Geriatric Nutritional Risk Index: A new index for evaluating at-risk elderly medical patients. Am J Clin Nutr 82: 777-783, 2005 (Pubitemid 43779690)
20. Wu CC, Chen JS, Wu WM, Liao TN, Chu P, Lin SH, Chuang CH, Lin YF: Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes. Nephrol Dial Transplant 20: 1134-1139, 2005 (Pubitemid 40862102)
21. Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, Hassan K, Shkolnik G, Geron R, Kristal B: Primed peripheral polymorphonuclear leukocyte: A culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 16: 2431-2438, 2005 (Pubitemid 41725061)
22. Chiang K, Parthasarathy S, Santanam N: Estrogen, neutrophils and oxidation. Life Sci 75: 2425-2438, 2004
23. Klebanoff SJ: Estrogen binding by leukocytes during phagocytosis. J Exp Med 145: 983-998, 1977
24. Kramer HM, Curhan G, Singh A: Hemodialysis and estrogen levels in postmenopausal (HELP) patients: The multicenter HELP study. Am J Kidney Dis 41: 1240-1246, 2003 (Pubitemid 36637980)
25. Tanaka M, Itoh K, Matsushita K, Matsushita K, Fukagawa M: High serum estradiol concentrations in postmenopausal women with end-stage renal disease. Clin Nephrol 64: 394-396, 2005 (Pubitemid 41671894)
26. Mohsenin V, Gee JL: Oxidation of alpha 1-protease inhibitor: role of lipid peroxidation products. J Appl Physiol 66: 2211-2215, 1989 (Pubitemid 19142372)
27. Schleicher E, Friess U: Oxidative stress AGE, and atherosclerosis. Kidney Int (Suppl): S17-S26, 2007
28. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38: 1251-1263, 2001 (Pubitemid 34193111)
29. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN: What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 11: 8-13, 1987 (Pubitemid 17009508)
30. Steiber AL, Kalantar-Zadeh K, Secker D, McCarthy M, Sehgal A, McCann L: Subjective Global Assessment in chronic kidney disease: A review. J Ren Nutr 14: 191-200, 2004 (Pubitemid 39360974)
31. Borawski J, Naumnik B, Mysliwiec M: Serum alpha1-antitrypsin but not complement C3 and C4 predicts chronic inflammation in hemodialysis patients. Ren Fail 25: 589-593, 2003 (Pubitemid 36944738)
32. Horl WH, Stepinski J, Schafer RM, Wanner C, Heidland A: Role of proteases in hypercatabolic patients with renal failure. Kidney Int Suppl 16: S37-S42, 1983 (Pubitemid 14109386)
33. Carp H, Janoff A: Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro. J Clin Invest 66: 987-995, 1980 (Pubitemid 11233799)
34. Moraga F, Janciauskiene S: Activation of primary human monocytes by the oxidized form of alpha1-antitrypsin. J Biol Chem 275: 7693-7700, 2000 (Pubitemid 30159672)
35. Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, Chatzipanagiotou S, Nicolaou C: The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transplant 19: 150-157, 2004 (Pubitemid 38072626)